Ionis Pharmaceuticals | IONS - Przychody Ze Sprzedaży





Obroty Zmiana Data
Agios Pharmaceuticals USD 19.97M 7.07M 2025-12
Alnylam Pharmaceuticals USD 1.1B 150M 2025-12
Arrowhead Research USD 264.03M 7.56M 2025-12
Astellas Pharma JPY 571.21B 46.89B 2025-12
BioCryst Pharmaceuticals USD 406.56M 247.16M 2025-12
BioMarin Pharmaceutical USD 875M 99M 2025-12
Celltrion KRW 1.33T 0 2026-03
Cspc Pharmaceutical CNY 6.62B 358.95M 2025-09
Deva Holding AS TRY 2.32B 418.58M 2023-09
Divis Laboratories Ltd INR 26.04B 1.11B 2025-12
Esperion Therapeutics USD 168.45M 81.14M 2025-12
Exelixis USD 598.66M 860K 2025-12
Halozyme Therapeutics USD 451.76M 97.76M 2025-12
Ionis Pharmaceuticals USD 203M 46M 2025-12
Kangmei Pharma CNY 1.37B 101.16M 2025-09
Knight Therapeutics CAD 133.11M 11.56M 2025-12
Laboratorios Farma EUR 448.66M 67.82M 2023-12
Medical Developments International AUD 21.57M 12.04M 2025-12
Moderna USD 678M 342M 2025-12
Nektar Therapeutics USD 24.12M 635K 2024-09
Neuren Pharmaceuticals AUD 42.24M 28.1M 2025-12
Neurocrine Biosciences USD 805.5M 10.6M 2025-12
Novartis USD 13.86B 50M 2025-12
OPKO Health USD 148.45M 3.22M 2025-12
Organigram Holdings CAD 63.54M 16.52M 2025-12
Pfizer USD 17.58B 880M 2025-12
Pharma Mar EUR 90.2M 54.5M 2025-12
PTC Therapeutics USD 164.7M 46.3M 2025-12
Qiagen NV USD 457.38M 6.06M 2025-12
Regeneron Pharmaceuticals USD 3.88B 130M 2025-12
Roche Holding CHF 15.65B 274.5M 2025-12
Sarepta Therapeutics USD 442.9M 43.5M 2025-12
Sartorius EUR 927.6M 84.4M 2025-12
Sino Biopharmaceutical CNY 17.57B 4.58B 2025-06
Tilray USD 217.51M 74.75M 2025-12
Ultragenyx Pharmaceutical USD 207M 47M 2025-12
Vertex Pharmaceuticals USD 3.19B 110M 2025-12
Zealand Pharma A/S 68.91M 19.35M 2025-12
Zhangzhou Pientzehuang Pharmaceutical CNY 2.88B 642.99M 2025-09